Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
CEENU BRISTOL-MYERS SQUIBB CANADA Anticipated shortage 40MG Updated Report 2021-01-27 130007
KINEVAC BRACCO IMAGING CANADA Anticipated shortage 5MCG New Report 2021-01-27 132553
CHOLETEC BRACCO IMAGING CANADA Actual shortage 45MG Updated Report 2021-01-27 122962
XYLOCAINE 2% W EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Actual shortage 20MG 5MCG Updated Report 2021-01-27 131563
ELETRIPTAN PRO DOC LIMITEE Actual shortage 40MG Updated Report 2021-01-27 121563
RILUTEK SANOFI-AVENTIS CANADA INC Actual shortage 50MG Updated Report 2021-01-27 98763
APRESOLINE STERIMAX INC Actual shortage 20MG Updated Report 2021-01-27 91935
PMS-NIFEDIPINE ER PHARMASCIENCE INC Actual shortage 30MG Updated Report 2021-01-27 93825
PMS-NIFEDIPINE ER PHARMASCIENCE INC Actual shortage 60MG Updated Report 2021-01-27 98823
DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML PFIZER CANADA ULC Anticipated shortage 150MG Updated Report 2021-01-27 131489
DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML PFIZER CANADA ULC Anticipated shortage 150MG Updated Report 2021-01-27 131486
APO-GABAPENTIN APOTEX INC Resolved 300MG Updated Report 2021-01-27 132355
SUBLOCADE INDIVIOR UK LIMITED Resolved 300MG Updated Report 2021-01-27 123466
APO METOPROLOL (TYPE L) APOTEX INC Actual shortage 50MG Updated Report 2021-01-26 132358
APO-CELECOXIB APOTEX INC Actual shortage 100MG Updated Report 2021-01-26 131815
APO-RAMIPRIL APOTEX INC Actual shortage 2.5MG Updated Report 2021-01-26 131166
APO-FENO-SUPER APOTEX INC Resolved 160MG Updated Report 2021-01-26 132352
NEXIUM - 20MG ASTRAZENECA CANADA INC Anticipated shortage 20MG Updated Report 2021-01-26 131188
ACYCLOVIR SODIUM INJECTION PFIZER CANADA ULC Anticipated shortage 25MG Updated Report 2021-01-26 130355
FOLIC ACID INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 5MG Updated Report 2021-01-26 107559

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
DDAVP RHINYLE FERRING INC To be discontinued 0.1MG New Report 2021-01-26 132472
APO-CELECOXIB APOTEX INC Discontinued 200MG Updated Report 2021-01-21 60366
IMURAN ASPEN PHARMACARE CANADA INC. To be discontinued 50MG Updated Report 2021-01-21 128667
INVIRASE HOFFMANN-LA ROCHE LIMITED Discontinued 500MG New Report 2021-01-20 132101
HUMATROPE ELI LILLY CANADA INC Discontinued 1MG Updated Report 2021-01-18 106800